Insider · CIK 0002101360
Minnie Kuo
Files at PLRX (PLIANT THERAPEUTICS, INC.). First filing Jan 22, 2026, latest Jan 22, 2026.
In brief
Minnie Kuo files SEC Form 4 as COO at PLRX (PLIANT THERAPEUTICS, INC.). Since Jan 22, 2026, Minnie Kuo has reported 0 open-market buys worth $0 and 1 open-market sell worth $8,854, the latest filed on Jan 22, 2026.
A track record needs three past buys with six months of prices behind them; Minnie Kuo has 0, so none is measured yet.
The newest scored trade: sold $8,854 of PLRX on Jan 20, 2026, filed Jan 22, 2026, scored 20 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $8,854.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PLRX: PLIANT THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | PLIANT THERAPEUTICS, INC. | $8,854 6,917 shares | -15% | +10% from low-90% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -150,000 | $0.00 | $0 | 0 | Apr 17, 2026 |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Apr 17, 2026 |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -40,000 | $0.00 | $0 | 0 | Apr 17, 2026 |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Apr 17, 2026 |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -55,200 | $0.00 | $0 | 0 | Apr 17, 2026 |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +55,200 | $0.00 | $0 | 55,200 | Apr 17, 2026 |
| Jan 22, 2026 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Jan 26, 2026 |
| Jan 20, 2026 | PLRX PLIANT THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,917 | $1.28 | $8,854 | 37,806 | Jan 22, 2026 |
Questions about Minnie Kuo
Answered from the filings on this page, as of the latest one.
Is Minnie Kuo buying or selling?
In the last 12 months Minnie Kuo reported 0 open-market buys worth $0 and 1 open-market sell worth $8,854 on SEC Form 4; the latest was sold $8,854 of PLRX on Jan 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Minnie Kuo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Minnie Kuo has 0.
Where does Minnie Kuo file Form 4?
Minnie Kuo has filed Form 4 at PLRX (PLIANT THERAPEUTICS, INC.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.